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Abstract. 
 
Calreticulin is a ubiquitous Ca
 
2
 
1
 
 binding pro-
tein, located in the endoplasmic reticulum lumen, 
which has been implicated in many diverse functions in-
cluding: regulation of intracellular Ca
 
2
 
1
 
 homeostasis, 
chaperone activity, steroid-mediated gene regulation, 
and cell adhesion. To understand the physiological 
function of calreticulin we used gene targeting to create 
a knockout mouse for calreticulin. Mice homozygous 
for the calreticulin gene disruption developed ompha-
locele (failure of absorption of the umbilical hernia) 
and showed a marked decrease in ventricular wall 
thickness and deep intertrabecular recesses in the ven-
tricular walls. Transgenic mice expressing a green ﬂuo-
rescent protein reporter gene under the control of the 
calreticulin promoter were used to show that the cal-
reticulin gene is highly activated in the cardiovascular 
system during the early stages of cardiac development. 
Calreticulin protein is also highly expressed in the de-
veloping heart, but it is only a minor component of the 
mature heart. Bradykinin-induced Ca
 
2
 
1
 
 release by the 
 
InsP
 
3
 
-dependent pathway was inhibited in 
 
crt
 
2
 
/
 
2
 
 cells, 
suggesting that calreticulin plays a role in Ca
 
2
 
1
 
 homeo-
stasis. Calreticulin-deﬁcient cells also exhibited im-
paired nuclear import of nuclear factor of activated T 
cell (NF-AT3) transcription factor indicating that cal-
reticulin plays a role in cardiac development as a com-
ponent of the Ca
 
2
 
1
 
/calcineurin/NF-AT/GATA-4 tran-
scription pathway.
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T
 
HE
 
 ER performs an important role in controlling
different intracellular processes including: protein
synthesis, folding and modification, synthesis of
 
membrane lipids, and regulation of Ca
 
2
 
1
 
 storage and re-
lease. The ER lumen contains a characteristic set of resi-
dent proteins that are involved in many aspects of ER
function, including Ca
 
2
 
1
 
 binding and storage. One of the
major Ca
 
2
 
1
 
 binding chaperone proteins of the ER is cal-
reticulin (Michalak et al., 1992). Calreticulin is an unusual
lumenal ER protein. The protein contains both high affin-
 
ity and high capacity Ca
 
2
 
1
 
 binding sites (Ostwald and
MacLennan, 1974; Baksh and Michalak, 1991) and has
been implicated in the regulation of cytoplasmic Ca
 
2
 
1
 
 ho-
meostasis, even though it is located in the ER lumen (Liu
et al., 1994; Bastianutto et al., 1995; Camacho and Lech-
 
leiter, 1995; Mery et al., 1996; Coppolino et al., 1997; Faso-
lato et al., 1998; John et al., 1998).
This regulatory function may be mediated by different
Ca
 
2
 
1
 
 binding sites in calreticulin (Baksh and Michalak,
1991; Krause and Michalak, 1997) and by the interaction
of calreticulin with inositol 1,4,5-trisphosphate (InsP
 
3
 
)
 
1
 
 re-
ceptors and/or SERCA molecules (John et al., 1998).
Other functions have been demonstrated for calreticulin
including: modulation of gene expression (Burns et al.,
1994; Dedhar et al., 1994; Michalak et al., 1996), chaper-
one activity (Nigam et al., 1994; Nauseef et al., 1995; Hele-
nius et al., 1997), and regulation of cell adhesion (Cop-
polino et al., 1995, 1997; Opas et al., 1996). Calreticulin has
also been reported to play a role in replication of Rubella
virus RNA (Singh et al., 1994), in cytotoxic T-cell function/
activation (Burns et al., 1992; Dupuis et al., 1993; Andrin
et al., 1998), in neutrophils (Stendahl et al., 1994), in sperm
 
1. 
 
Abbreviations used in this paper:
 
 ES cells, embryonic stem cells; GFP,
 
green fluorescent protein; InsP
 
3
 
, inositol 1,4,5-trisphosphate; NF-AT, nu-
clear factor of activated T cell. 
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cell function (Nakamura et al., 1993), and in autoimmunity
(Sontheimer et al., 1993).
The aim of this study was to investigate the physiologi-
cal functions of calreticulin by generating a calreticulin-
deficient mouse. The homozygous calreticulin knockout
was an embryonic lethal because of defects in heart devel-
opment and function. This was a surprising result because
calreticulin is an ER lumenal protein and only a minor
component of the mature heart (Fliegel et al., 1989a,b;
Milner et al., 1991; Tharin et al., 1996). However, we gen-
erated transgenic mice expressing the green fluorescent
protein (GFP) under the control of calreticulin promoter
and showed that the calreticulin gene was activated during
early stages of embryonic development. Furthermore, cal-
reticulin-deficient cells have inhibited bradykinin-induced
Ca
 
2
 
1
 
 release from the ER and impaired nuclear import of
the NF-AT3 transcription factor.
 
Materials and Methods
 
Construction of the Calreticulin Knockout Vector
 
The plasmid pNTK (containing the PGK neomycin cassette and PGK thy-
midine kinase) was used to generate the knockout vector. The calreticulin
promoter was cloned previously from a mouse liver genomic library
(Waser et al., 1997) and digested by SalI and HindIII restriction endonu-
cleases. Afterwards, the 1.5-kb fragment was blunt ended and ligated into
the pNTK plasmid to generate the pNTC1 plasmid. The plasmid pCM101
containing the full-length mouse calreticulin gene was cut with EcoRV.
Furthermore, an 11-kb fragment, containing part of exon 4 and exons 5–9
and 3-kb of 3
 
9
 
 flanking region, was ligated with the NotI/SalI cut and
blunted pNTC1 plasmid that resulted in the calreticulin gene knockout
construct pNTC6 (see Fig. 1 A). In the pNTC6 plasmid the PGK NEO
cassette replaced the first four exons of the calreticulin gene, thus remov-
ing the proposed transcription initiation site, the ATG start codon, and in-
terrupting translation of the protein.
 
Electroporation, Selection, and Screening of ES
Cell Clones
 
J1 129/Sv embryonic stem (ES) cells (5 
 
3
 
 10
 
7
 
) were electroporated with
100 
 
m
 
g of linearized pNTC6 vector using a Bio-Rad Gene Pulser at 400
V/cm and 25 
 
m
 
F. Cells were plated on mitomycin C–treated G-418–resis-
tant mouse embryonic fibroblast feeder cells. Recombinant clones
were  selected with G418 (0.2 mg/ml) and gancyclovir (2 
 
m
 
M). 200 colonies
were picked after 10 d in selection medium and expanded. 100 clones were
screened for a homologous recombination event by PCR using the Ex-
pand Long Template PCR System (Boehringer Mannheim). The effi-
ciency of homologous recombination was 1 in 30 clones. The heterozygote
calreticulin knockout ES cells were identified by PCR using one 5
 
9
 
 primer
(5
 
9
 
-GCTGGTCAAGTGTGATTCTCATGTTCCTGCCTG-3
 
9
 
) and two
different 3
 
9
 
 primers (5
 
9
 
-CTCTGACCTTCACACTAGACACCCTTC-
ATC-3
 
9
 
 for the wild-type gene and 5
 
9
 
-CTCTGACCTTCACACTAGA-
CACCCTTCATC-3
 
9
 
 for the knockout allele) and confirmed by Southern
blot analysis. These ES cells were microinjected into 3.5-d-old C57BL/6J
blastocysts to generate chimeric mice. Chimeric males were analyzed for
germline transmission by mating with C57BL/6J females, and the progeny
were analyzed by PCR and Southern blot. For PCR amplification of the
genomic DNA of knockout mice, two sets of primers were utilized (see
Fig. 1 A). One resulted in detection of the wild-type gene (the primer se-
quences were: 5
 
9
 
-GAAGATCTAAACCAGTCAAAAGGACC-3
 
9
 
 and
5
 
9
 
-CTCCAGGTCCCCGTAAAATTTGCC-3
 
9
 
) and the second resulted
in detection of the targeted knockout construct (the primer sequences
were: 5
 
9
 
-CAGAGATCTCAGCAGCAAGGGC-3
 
9
 
 and 5
 
9
 
-CTCTGACC
TTCACACTAGACACCCTTCATC-3
 
9
 
). EcoRI-digested genomic DNA
was used for Southern blot detection of the calreticulin gene and for de-
tection of the targeted mutant allele using the 5
 
9
 
 DNA probe indicated in
Fig. 1 A.
 
Generation of the GFP Reporter Gene Vector
 
The plasmid pS65T-C1 containing cDNA encoding GFP was purchased
from CLONTECH Laboratories, Inc. The nucleotide sequence corre-
sponding to the CMV promoter of this construct was removed using AseI
and NheI restriction sites and the ends were blunted using Klenow poly-
merase. The CMV promoter was replaced with a 2.3-kb mouse calreticulin
promoter (Waser et al., 1997), and cut with SmaI and StuI to generate
blunt ends. The 3.58-kb vector containing the calreticulin promoter, GFP
cDNA, and the SV-40 polyA site is referred to as the pCPGF construct.
To generate transgenic mice, pCPGF was linearized with NaeI/SpeI (see
Fig. 3 A), purified, and injected into the fertilized oocytes from the
FVB/N mice (Taketo et al., 1991). Afterwards cells were transferred into
pseudopregnant FVB/N mice. Genomic DNA was isolated from tail biop-
sies of each of the transgenic mouse litters and the presence of the GFP
reporter targeting vector was detected by PCR using a 5
 
9
 
 primer in the
CRT promoter region (5
 
9
 
-GATTCCTTCTGGGCAGTTCATAGTC-3
 
9
 
)
and a 3
 
9
 
 primer in the GFP protein cDNA (5
 
9
 
-ATCTAATTCAACAA-
GAATTGGGACAA-3
 
9
 
). The locations of these primers are indicated in
Fig. 3 A. Transgenic animals and calreticulin-deficient mice were gener-
ated in the Transgenic Facility (University of Alberta Health Sciences
Laboratory Animal Services, Edmonton, Alberta, Canada).
 
Histological Analysis
 
Mouse embryos, at different gestational age, were dissected out of the
uterus and fixed in 4% paraformaldehyde for 30–90 min. The embryos
were embedded in 30% sucrose overnight at 4
 
8
 
C, washed once in PBS for
1 h, placed in 50% Tissue Tek OCT compound (mounting media) in PBS
saline for 8 h at room temperature, and incubated in 100% OCT overnight
at 4
 
8
 
C. The embryos were frozen in 2-methylbutane cooled in liquid nitro-
gen. Cryostat sections, 8–10 
 
m
 
m thick, were prepared in transverse and
sagittal sections. The sections were either mounted in mounting media
containing 0.2% DABCO (for fluorescence analysis) or processed for im-
munohistochemistry and standard hematoxylin and eosin staining. A con-
focal microscope (MRC600; Bio-Rad Laboratories) was used to obtain
images at 10
 
3
 
 or 60
 
3
 
 and images were reconstructed using the Adobe
Photoshop program. For better visualization, simulated phase-contrast
images of each fluorescent image were generated using the Adobe Photo-
shop program.
 
Immunohistochemistry
 
Sections from wild-type and transgenic mouse embryos were stained with
appropriate antibodies followed by staining using Vectastain Elite ABC
kit and Vector DAB substrate kit (Vector Labs Inc.). Primary antibodies
were polyclonal rabbit antibodies to GFP (1:150 dilution; CLONTECH
Laboratories, Inc.) and affinity purified anticalreticulin (1:10 dilution)
(CRT283 antibody described in Michalak et al., 1996). The sections were
counterstained with hematoxylin.
 
Activation of NF-AT3 in Mouse Embryonic Fibroblasts
 
Embryos from two litters of heterozygous crosses were used to derive
mouse embryonic fibroblasts. Embryos 
 
crt
 
2
 
/
 
2
 
 and wild-type genotype
were dissociated, washed, trypsinized for 30 min, and cultured in 6-well
tissue culture plates. Cells were maintained in DME containing 20% FCS.
For transfection experiments, plasmid DNA was purified by column chro-
matography (Qiagen Inc.). Cells were transfected transiently with NF-
AT3 expression vector alone, or cotransfected with NF-AT3 and calreti-
culin expression vectors as described by Burns et al. (1994). After 1 d, cells
were stimulated with 200 nM bradykinin (Waser et al., 1997) followed by
indirect immunofluorescence with monoclonal anti–NF-AT (mAb 7A6, a
gift of G.R. Crabtree, Stanford University) and polyclonal goat antical-
reticulin antibodies (Milner et al., 1991). The secondary antibodies were:
Texas red–conjugated sheep anti–mouse (diluted 1:50 in PBS) and FITC-
conjugated donkey anti–goat (used at 1:50 dilution). For double labeling,
all incubations were carried out sequentially. A confocal fluorescence mi-
croscope (MRC-600; Bio-Rad Laboratories) equipped with a krypton/ar-
gon laser light source was used.
 
Ca
 
2
 
1
 
 Measurements
 
Wild-type and calreticulin-deficient mouse embryonic fibroblasts (1.5 
 
3
 
10
 
6
 
 cells/ml) were loaded with fura-2/AM (Molecular Probes, Inc.). Fluo- 
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rescence measurements were carried out as described by Mery et al.
(1996). Ca
 
2
 
1
 
 release from internal stores was induced with either 1 
 
m
 
M
thapsigargin (Sigma Chemical Co.), or 200 nM bradykinin (Sigma Chemi-
cal Co.). Changes in the cytoplasmic Ca
 
2
 
1
 
 concentration were monitored
in Ca
 
2
 
1
 
-free media (Mery et al., 1996).
 
Miscellaneous
 
Proteins were separated by SDS-PAGE on 10% polyacrylamide gels as
described by Laemmli (1970), transferred to nitrocellulose membranes,
and stained by immunoblotting with affinity purified rabbit anticalreticu-
lin antibody (Michalak et al., 1996).
Genomic DNA was isolated from mouse tissue as described by
Ausubel et al. (1989) and digested with EcoRI. The DNA was separated
by electrophoresis on 0.8% agarose gel and transferred to Hybond-N
membranes (Amersham Pharmacia Biotech). The disruption of the cal-
reticulin gene was characterized by Southern blotting (Ausubel et al.,
1989).
 
Results
 
Calreticulin Knockout
 
Fig. 1 A summarizes the gene targeting strategy used to
generate the calreticulin gene knockout mice. During the
process of homologous recombination, the PGK NEO cas-
sette was inserted into the calreticulin gene, replacing the
first four exons, thus removing the initiator ATG and in-
terrupting the expression of calreticulin protein (Fig. 1 A).
PCR analysis of genomic DNA using the specific sets of
primers depicted in Fig. 1 A helped to identify the geno-
type of the mice. Analysis of genomic DNA by Southern
blotting (Fig. 1 B) showed two hybridizing bands in ge-
nomic DNA from 
 
crt
 
1
 
/
 
2
 
 mice corresponding to the wild-
type allele (5.7 kb) and the targeted knockout allele (3.8 kb),
whereas Southern blotting of genomic DNA isolated from
 
crt
 
2
 
/
 
2
 
 mice (Fig. 1 B) showed only one DNA band of 3.8 kb
corresponding to the size of the targeted knockout gene.
Western blot analysis revealed that the interruption of a
single allele in 
 
crt
 
1
 
/
 
2
 
 mice resulted in a significant decrease
in calreticulin protein level, whereas in the calreticulin
gene knockout animals (
 
crt
 
2
 
/
 
2
 
) there was no detectable
expression of the protein (Fig. 1 C). 
 
crt
 
1
 
/
 
2
 
 mice contained
 
z
 
50% lower level of calreticulin protein than wild-type
mice, as estimated by densitometry. Identical results were
obtained with three different anticalreticulin antibodies
(not shown).
 
Phenotype of Calreticulin Knockout Mice
 
Chimeric male mice were crossed with wild-type females
to generate first generation heterozygotes. The 
 
crt
 
1
 
/
 
2
 
 mice
had normal phenotype, being viable and fertile. Inter-
crossing of the 
 
crt
 
1
 
/
 
2
 
 males with 
 
crt
 
1
 
/
 
2
 
 females was carried
out to generate homozygote (
 
crt
 
2
 
/
 
2
 
) gene knockout mice.
We were unable to obtain any viable 
 
crt
 
2
 
/
 
2
 
 pups from this
cross. Living 
 
crt
 
2
 
/
 
2
 
 embryos were obtained at 18 d and ear-
lier. In addition, a number of 12.5–16.5-d-old embryos
were dead. Analysis of embryos at or after day 14.5
showed a deficit number of 
 
crt
 
2
 
/
 
2
 
 embryos (15% instead
of 25%), indicating that a significant fraction of 
 
crt
 
2
 
/
 
2
 
 em-
bryos died earlier. We concluded that the homozygote
(
 
crt
 
2
 
/
 
2
 
) gene knockout was embryonic lethal and that cal-
reticulin is essential for survival.
Accordingly, serial timed matings were set up to follow
 
embryonic development in an attempt to find the cause of
death of the 
 
crt
 
2
 
/
 
2
 
 mice. Fig. 2, A and B, shows photo-
graphs of 18-d-old 
 
crt
 
1
 
/
 
2
 
 (left) and 
 
crt
 
2
 
/
 
2
 
 (right) mouse
embryos. At this level of analysis the most visible differ-
ence between the 
 
crt
 
1
 
/
 
2
 
 and crt2/2 embryos was the failure
of absorption of the umbilical hernia (omphalocele) in the
crt2/2 embryos (Fig. 2, A and B, arrow). Histological anal-
ysis of crt2/2 mice confirmed the omphalocele and the
presence of midgut in the umbilical hernia (Fig. 2 B).
The other significant defect was observed in morphology
of the hearts of the crt2/2 mice (Fig. 2 B). Fig. 2 B shows
that there was a marked decrease in the thickness of the
Figure 1. Targeted disruption of the calreticulin gene. (A) Top
shows the structure of the mouse calreticulin gene, indicating the
ATG start codon and the restriction enzymes utilized (E, EcoRI;
EV, EcoRV; H, HindIII; S, SalI). The arrows indicate the PCR
primer sets (see Materials and Methods) used for recognition of
the wild-type gene. The solid bar is the 59 probe used for South-
ern blotting. Middle is the targeting vector designed to replace
the first exons with the PGK NEO cassette. The targeted calre-
ticulin allele is shown (bottom). The arrows indicate the PCR
primers used for recognition of the mutant allele. (B) Southern
blot of the EcoRI-digested genomic DNA isolated from wild-
type (1/1), heterozygote (1/2), and homozygote (2/2) mice.
The sizes of the wild-type (5.7 kb) and mutant allele (3.8 kb) are
indicated. (C) Western blot analysis of proteins extracted from
the biopsies of wild-type (1/1), heterozygote (1/2), and ho-
mozygote (2/2) mouse embryos. The blot was probed with the
affinity-purified rabbit anticalreticulin antibody (Michalak et al.,
1996).The Journal of Cell Biology, Volume 144, 1999 860
ventricular wall in crt2/2 as compared to crt1/2 mice. His-
tological analysis of 12.5-d-old crt2/2 embryo also revealed
defects in morphology of the heart (Fig. 2 C), indicating
that calreticulin is essential for cardiac development at rel-
atively early stages of cardiogenesis. No other gross mor-
phological changes were detected in crt2/2 mice (Fig. 2).
Higher magnification analysis of hearts from 12.5-, 14.5-,
and 18-d-old embryos revealed deep intertrabecular re-
cesses and increased fenestration that were associated with
the thinner ventricular wall (Fig. 3). However, no signifi-
cant changes in the histology of the atrial wall was ob-
served (Figs. 2 and 3). At high magnification, pictures of
the ventricular wall of 18-d-old crt2/2 embryo further dem-
onstrate all of the following: increased fenestration, thin-
ner ventricular wall, and the impaired growth of the com-
pact layer of the ventricles as compared to the crt1/2
embryos (Fig. 4).
Developmental Activation of the Calreticulin Promoter
The mature heart contains a very low level of calreticulin
(Fliegel et al., 1989a,b; Milner et al., 1991; Tharin et al.,
1996) but histological analysis of calreticulin-deficient
mice suggests an essential role for the protein in cardiac
development. To answer the question of whether the cal-
reticulin gene is activated during cardiac development we
studied the activation of its promoter in transgenic mice
expressing the GFP reporter gene under control of the cal-
reticulin promoter. Fig. 5 A illustrates the strategy used to
construct the reporter transgene. The calreticulin pro-
moter (2.3 kb) was introduced upstream of the GFP re-
porter gene. Genomic DNA from the transgenic mice was
analyzed by PCR for the presence of the GFP transgene
(Fig. 5 B). Three separate transgenic founder mice (L9,
L13, and L17) were generated and all three gave identical
results. Activation of the calreticulin promoter was moni-
tored by detection of the fluorescent signal obtained from
calreticulin promoter-driven expression of the GFP re-
porter gene. The first generation (F1) male transgenic
mice were used in serial timed matings with wild-type
FVB/N females. Embryos were harvested at different ges-
tation times, fixed, and frozen. Every embryo was tested
Figure 2. Phenotypes of heterozygote (crt1/2) and homozygote
(crt2/2) mouse embryos. (A) Phenotypes of 18-d-old crt1/2 and
crt2/2 mouse embryos are shown. The arrow indicates the umbil-
ical hernia. Leg and tail biopsies were removed for better visual-
ization of the defect and were used for DNA and protein analysis.
(B) Low magnification histology of 18-d-old crt1/2 and crt2/2
mouse embryos is shown. The arrow indicates the umbilical her-
nia. (C) Phenotypes of wild-type (wt) and homozygote (crt2/2)
12.5-d-old mouse embryos. Sagittal sections of embryos were
stained with eosin and hematoxylin.Mesaeli et al. Calreticulin and Heart Development 861
for the presence of the GFP transgene by PCR, followed
by analysis of sections prepared from the transgenic and
wild-type littermates.
Fig. 6, A and B, shows sagittal sections of a 9.5-d-old
transgenic mouse embryo. The highest fluorescent signal,
indicative of high expression of GFP, was found in the car-
diovascular system including: ventricular walls, atrial walls,
aortic sac, sinus venosus, dorsal aorta, and some of the
smaller arteries (e.g., branchial arch arteries). This indi-
cates that the highest activity of the calreticulin promoter
occurs in these tissues at day 9.5 of embryonic develop-
ment. The optic vesicle and the lining of brain ventricles
also exhibited high calreticulin promoter activity (Fig. 6, A
and B). At 10.5 d of embryonic development the calreticu-
lin promoter remained highly active in cardiovascular and
brain tissue, but its activity was also detected in the midgut
and in intersomitic vessels (Fig. 6, C and D). In older em-
bryos (13.5-d-old) high activity of the calreticulin pro-
moter was maintained in the heart and arteries (Fig. 6 E).
In addition, activation of the calreticulin promoter was
also seen in the liver, midgut, and the umbilical hernia.
A high level of activation of the calreticulin promoter
continued in the cardiovascular system and umbilical her-
nia in the 14.5-d-old mouse embryo (Fig. 7 A). The expres-
sion of GFP reporter protein was localized exclusively to
the cytosol of the myocytes of atria and ventricles (Fig. 7
B). There was no fluorescent signal in the thoracic wall
and blood cells, indicating differential expression of GFP
in these tissues. At late stages of development (18-d-old
embryos) a relatively low fluorescent signal, indicative of a
lower expression of GFP, was found in the heart (Fig. 7 C).
A negligible level of fluorescence was found in the heart of
3-wk-old transgenic mice (Fig. 7 E). This indicates that the
activity of the calreticulin promoter is downregulated at
late stages of development and after birth. These findings
are in agreement with earlier observations that mature
hearts express a low level of calreticulin (Fliegel et al.,
1989a,b; Milner et al., 1991; Tharin et al., 1996).
To confirm the expression of GFP protein was under the
control of the calreticulin promoter in the cardiovascular
system, we carried out immunohistological analysis of
GFP transgenic embryos. Fig. 8 shows immunohistological
staining of sagittal section of hearts from transgenic mice
with antibodies to GFP. In agreement with observed fluo-
rescent signals of GFP (Figs. 6 and 7) the protein was
highly expressed in the embryonic heart (Fig. 8, C and D).
There was no staining of the wild-type embryonic heart
with anti-GFP antibodies (Fig. 8, A and B). To determine
if activation of the calreticulin promoter correlated with
expression of calreticulin protein we carried out immuno-
histological analysis of mouse embryos with anticalreticu-
lin antibodies. Fig. 9 shows low (A–D) and high (A9–D9)
magnification of immunohistological staining of 9.5- (A,
A9), 13.5- (B, B9), and 18- (C, C9) d-old embryos and ma-
ture (D) hearts. Calreticulin protein was highly expressed
in myocytes during early stages of embryonic development
(Fig. 9, A9, B9, and C9). The highest expression of calre-
ticulin was observed in the 13.5-d-old embryonic heart
Figure 3. Histology of the hearts from crt1/2 and crt2/2 embryos.
A, B, and C show histological analysis of the 12.5-, 14.5-, and 18-
d-old crt1/2 embryos, respectively. A9, B9, and C9 show histology
of the 12.5-, 14.5-, and 18-d-old crt2/2 embryos. crt2/2 embryos
show deep intertrabecular recesses and increased fenestration
associated with the thinner ventricular wall. Sections were
stained with hematoxylin and eosin as described in Materials and
Methods.
Figure 4. Histological analysis of the heart of crt1/2 and crt2/2 18-
d-old embryos. Sections were stained with hematoxylin and eosin
as described in Materials and Methods. The upper panel shows
the apex of the heart in crt1/2 and crt2/2 embryos. The lower
panel shows ventricular walls in crt1/2 and crt2/2 animals.The Journal of Cell Biology, Volume 144, 1999 862
(Fig. 9 B9). In agreement with our earlier biochemical
studies (Fliegel et al., 1989a,b; Milner et al., 1991; Tharin
et al., 1996), virtually no staining for calreticulin was de-
tected in the mature heart (Fig. 9 D9). This is in full agree-
ment with the levels of GFP expressed in GFP transgenic
mice (Figs. 6 and 7).
Nuclear Translocation of NF-AT3 Is Impaired in 
Calreticulin Knockout Cells
Recent observations indicate that the NF-AT3 transcrip-
tion factor plays an important role in cardiac hypertrophy
and development (de la Pompa et al., 1998; Molkentin et al.,
1998; Ranger et al., 1998). The activation of NF-AT is con-
trolled by calcineurin, a Ca21 calmodulin-dependent phos-
phatase (Timmerman et al., 1996). Dephosphorylation of
NF-AT by activated calcineurin triggers its nuclear trans-
location (Rao et al., 1997). To determine whether the role
of calreticulin in cardiac development might be associated
with NF-AT nuclear translocation, we isolated mouse em-
bryonic fibroblasts from crt2/2 and wild-type embryos and
tested them for nuclear import of NF-AT3 transcription
factor. Cells were stimulated with bradykinin to induce de-
pletion of the intracellular Ca21 stores (Hashii et al., 1993;
Waser et al., 1997) and activation of calcineurin (Timmer-
man et al., 1996). Fig. 10 A shows that wild-type cells
expressed calreticulin and the protein is localized to an
ER-like network. As expected, there was no expression of
calreticulin in crt2/2 cells (Fig. 10 B). In wild-type cells
stimulated with bradykinin, NF-AT3 was efficiently trans-
located to the nucleus (Fig. 10 A9). However, nuclear im-
port of NF-AT3 in crt2/2 cells was impaired and the major-
ity of the transcription factor was found in the cytoplasm
(Fig. 10 B9) indicating that NF-AT3 transcription factor
was not efficiently translocated into the nucleus. Nuclear
translocation of NF-AT3 was reestablished in the crt2/2
cells transiently transfected with calreticulin expression
vector (Fig. 10, C and C9).
InsP3-dependent Ca21 Release Is Inhibited in 
Calreticulin-deficient Cells
It is well established that Ca21 release by the InsP3-depen-
Figure 5. Construction and analysis of the GFP re-
porter gene vector. (A) 2.3-kb calreticulin promoter
(Waser et al., 1997) was subcloned upstream of the
cDNA encoding GFP. The arrows show the loca-
tions of the primer set used for PCR-driven detec-
tion of integration of the transgene into the mice ge-
nome. (B) PCR analysis of the genomic DNA of
transgenic mice: lane M, molecular size ladder; lane
1, positive control purified plasmid DNA used as a
template; lane 2, wild-type mouse; and lanes 3 and 4,
GFP-transgenic mice.
dent pathway is required to activate calcineurin, leading to
nuclear import of NF-AT transcription factor (Timmer-
man et al., 1996; Dolmetsch et al., 1997; Kehlenbach et al.,
1998). To assess whether calreticulin-deficient cells exhibit
any alteration in Ca21 homeostasis, we used the fluores-
cent Ca21 indicator fura-2. Wild-type and crt2/2 mouse
embryonic fibroblasts were stimulated with either thapsi-
gargin, an inhibitor of SERCA type Ca21 pumps (Thas-
trup et al., 1990), or with bradykinin, a potent activator of
the InsP3-dependent Ca21 release channel located in the
ER (Hashii et al., 1993). When cells were stimulated with
thapsigargin, the peak amplitude and the duration of en-
hanced cytoplasmic Ca21 concentration were comparable
in wild-type and in crt2/2 mouse embryonic fibroblasts
(Fig. 11 A). Next we investigated the effects of bradykinin,
a receptor agonist known to activate phospholipase C and
InsP3-dependent Ca21 release from the ER (Hashii et al.,
1993). Fig. 11 B (solid line) shows that bradykinin caused a
rapid and transient increase in the cytoplasmic Ca21 con-
centration in wild-type cells, but not in crt2/2 mouse em-
bryonic fibroblasts (Fig. 10 B, dotted line). Ca21 release by
InsP3-dependent pathway was clearly impaired in calreti-
culin-deficient cells.
Discussion
In this study we demonstrated that disruption of the cal-
reticulin gene results in embryonic lethality. Analysis of
the crt1/2 and crt2/2 embryos showed defects in cardiac
morphology. The crt2/2 mice show a marked decrease in
ventricular wall thickness and deep intertrabecular re-
cesses in the ventricular walls. Investigation of the activa-
tion pattern of the calreticulin gene during embryonic de-
velopment revealed that at early stages of embryogenesis
the highest level of activation of the calreticulin gene was
in the cardiovascular system: ventricular walls, atrial walls,
aortic sac, sinus venosus, dorsal aorta, and some of the
smaller arteries. In later stages of embryogenesis a high ac-
tivity of the promoter in the cardiovascular system was
maintained, but activation of the gene was also seen in the
brain, midgut, intersomitic vessels, and, finally, in the liverMesaeli et al. Calreticulin and Heart Development 863
and the umbilical hernia. Analysis of InsP3-dependent
Ca21 release and of nuclear import of NF-AT3 transcrip-
tion factor in cells isolated from crt2/2 and wild-type mice
revealed that calreticulin is a component of the Ca21 regu-
latory system in these cells. Therefore, calreticulin influ-
ences the Ca21 and calcineurin-dependent pathway in de-
veloping heart.
In the adult, calreticulin is expressed mainly in nonmus-
cle and smooth muscle cells, and is only a minor compo-
nent of the skeletal muscle and cardiac sarcoplasmic retic-
ulum (Fliegel et al., 1989a,b; Milner et al., 1991; Tharin et
al., 1996). However, data presented in Figs. 6–9 show that
calreticulin is highly expressed in the cardiovascular sys-
tem during early embryogenesis. Thus, it was not surpris-
Figure 7. Confocal image of the hearts at different stages of de-
velopment. (A and B) Cross-sections of the heart from 14.5-d-old
embryo. GFP expression is localized to both atrial and ventricu-
lar walls but the fluorescent signal is also seen in the atrial and
ventricular trabeculae. (B) The highest fluorescent signal found
in the cardiomyocytes is shown. (C) GFP expression in the heart
of 18-d-old embryo. (D) A phase-contrast image of C. (E) A neg-
ligible level of expression of GFP in the heart of 3-wk-old mouse
is shown. (F) A phase-contrast image of E. Symbols: AC, atrial
chamber; B, blood cells; TW, thoracic wall; VT, ventricular tra-
beculae; and VW, ventricular wall.
Figure 6. Developmental activation of calreticulin promoter. (A
and B) Sagittal section of a 9.5-d-old mouse embryo expressing
the GFP reporter protein under the control of the calreticulin
promoter. (B) A phase-contrast of the image seen in A. (C and
D) Sagittal sections of 10.5-d-old mouse embryos from GFP
transgenic mice. (C) The first section shows high expression of
GFP in the atria (A) and ventricles (V). Fluorescent signals are
seen mainly in the cardiovascular and the nervous systems. (D)
Additional sections of the embryo shown in C indicate high fluo-
rescence in the intersomitic vessels (S). (E and F) Analysis of
13.5-d-old transgenic mouse embryo. (E) Confocal image show-
ing the fluorescent signal in the cardiovascular system, liver, gut,
and umbilical hernia. (F) A phase-contrast image of E. Tissues
expressing GFP show a highly fluorescent signal: A, atria; AS,
aortic sac; BA, branchial arteries and branches from the pulmo-
nary arteries and arches of the aorta; DA, dorsal aorta; FB, fore
brain; G, gut; HB, hind brain; L, liver; MB, mid brain; MG, mid-
gut; OV, optic vesicle; SV, sinus venosus; S, somite; UH, umbili-
cal hernia; and V, ventricles.The Journal of Cell Biology, Volume 144, 1999 864
ing to find that crt2/2 mice have defects in cardiac develop-
ment and function. The only other gross morphological
change in crt2/2 embryos was the failure to absorb the um-
bilical hernia. It is unlikely that embryonic lethality of cal-
reticulin-deficient mice occurs because of failure to absorb
the umbilical hernia since this pathology is not embryonic
lethal in humans (Byrne, 1991). Embryonic lethality of
crt2/2 mice most likely resulted from a lesion in cardiac de-
velopment.
Numerous functions have been postulated for calreticu-
lin including: modulation of steroid-mediated gene expres-
sion (Burns et al., 1994; Dedhar et al., 1994; Michalak et al.,
1996), chaperone activity (Helenius et al., 1997), regula-
tion of cell adhesion (Coppolino et al., 1995, 1997; Opas
et al., 1996), and regulation of Ca21 homeostasis (Liu et al.,
1994; Bastianutto et al., 1995; Camacho and Lechleiter,
1995; Mery et al., 1996; Coppolino et al., 1997; Fasolato
et al., 1998; John et al., 1998). A loss of any of these poten-
tial functions of calreticulin could lead to a lesion in car-
diac development. Because there were no obvious histological
abnormalities in any other tissues during embryogenesis, it
is unlikely that this is directly due to chaperone function of
calreticulin, or its role in the regulation of cell adhesion.
Cardiac development is an extremely complex process
under strict transcriptional control (Rossant, 1996; Fish-
man and Chien, 1997; Sucov, 1998; Creazzo et al., 1998).
The first morphogenetic event in mouse cardiac develop-
ment is the formation of a primordial heart tube by cells
that segregate from the splanchnic mesoderm in 7-d-old
embryos (DeRuiter et al., 1992). Between 8 and 9.5 d, the
primitive heart tube begins to exhibit rhythmic contrac-
tions and undergoes asymmetrical elongation, creating an
S-shape loop (DeRuiter et al., 1992). Later in embryogen-
esis, the growing heart progresses through several addi-
tional morphological stages including all of the following:
the formation of endocardial cushion tissue, septation, tra-
beculation, compaction (expansion of the ventricular wall),
and envelopment of the epicardial mantle (DeRuiter et
al., 1992; Mikawa and Fischman, 1996). Based on analo-
gies to skeletal myogenesis, it is presumed that cardiomyo-
cyte lineage commitment is directed by a group of tissue-
specific transcription factors (Olson and Srivastova, 1996).
However, the factors essential for cardiomyocyte differ-
entiation in vertebrates remain poorly characterized (Ol-
Figure 9. Immunohistochemical analysis of the transgenic mice
with anticalreticulin antibodies. Sagittal sections of 9.5- (A), 13.5-
(B), and 18- (C) d-old embryos and mature (D) mouse hearts
were stained with anticalreticulin antibodies followed by DAB
(brown color). High magnification picture (A9–D9) shows that
calreticulin protein was highly expressed in myocytes during
early stages of embryonic development (A9, B9, and C9). No sig-
nificant staining for calreticulin was detected in the mature heart
(D9). The sections were counterstained with hematoxylin.
Figure 8. Immunohistochemical analysis of the GFP transgenic
mice. Sagittal sections of 13.5-d-old mouse embryos were stained
with specific antibodies followed by DAB (brown color). The
sections were counter-stained with hematoxylin to visualize the
nuclei. Low (A) and high magnification (B) images from cryostat
sections of a wild-type mouse embryo stained with anti-GFP anti-
body. Low (C) and high (D) magnification images from GFP
transgenic mouse showing the GFP positive staining in the ven-
tricular myocytes.Mesaeli et al. Calreticulin and Heart Development 865
son and Srivastova, 1996). How can calreticulin, an ER lu-
menal protein, affect cardiac development? In this work
we have shown that nuclear import of NF-AT3 transcrip-
tion factor is impaired in crt2/2 cells indicating that calre-
ticulin plays a role in the Ca21/calcineurin/NF-AT/GATA-4
transcription pathway (Molkentin et al., 1998). Cardio-
myogenesis depends on activation of the GATA family of
transcription factors (Grepin et al., 1994; Evans, 1997).
GATA-4 null mice display a severe defect in the formation
of the cardiac tube, which is required for the migration and
folding of the precardiogenic splanchnic mesoderm (Kuo
et al., 1997; Molkentin et al., 1997). Furthermore, inhi-
bition of GATA-4 expression affects terminal cardiomyo-
cyte differentiation (Grepin et al., 1994). During cardiomyo-
genesis NF-AT, in the nucleus, forms active heterodimer
complexes with GATA-4 and significantly enhances its
transcriptional activity (Molkentin et al., 1998). The ability
of NF-AT to translocate to the nucleus depends on the ac-
tivation of calcineurin phosphatase activity and efficient
dephosphorylation of the transcription factor (Rao et al.,
1997). Therefore, it is not surprising that NF-AT–deficient
mice are not viable and the major defect in these animals
relates to cardiac development (de la Pompa et al., 1998;
Ranger et al., 1998).
Activation of calcineurin and nuclear import of NF-AT
requires Ca21 release by the InsP3-dependent pathway
(Timmerman et al., 1996; Dolmetsch et al., 1997). In this
study we show that calreticulin-deficient mouse embryonic
fibroblasts do not have a measurable InsP3-dependent
Ca21 release when stimulated with bradykinin. This is in
agreement with a previous report in which the Ca21 re-
sponse to bradykinin was diminished as a result of anti-
sense oligodeoxynucleotide downregulation of calreticulin
expression (Liu et al., 1994). Calreticulin is a Ca21-binding
protein that affects Ca21 storage in the ER lumen (Bas-
tianutto et al., 1995; Mery et al., 1996; Fasolato et al.,
1998). It may regulate function of the ER Ca21-release
channel (InsP3 receptor), Ca21-ATPase (SERCA2b) (Ca-
macho and Lechleiter, 1995; John et al., 1998), and store-
operated Ca21 influx (Mery et al., 1996). Camacho and
Lechleiter (1995) proposed that calreticulin may be re-
sponsible for modulation of the Ca21 release function of
the InsP3 receptor and/or of the Ca21 transport function of
SERCA. Recently, John et al. (1998) reported that calre-
ticulin may interact with SERCA2b, resulting in a lower
transport capacity by the Ca21-ATPase. Here we show
that loss of calreticulin reduces Ca21 release through the
InsP3 receptor. Despite inhibition of the InsP3-dependent
Ca21 release pathway, cardiomyocytes cultured from
14.5-d-old  crt2/2 embryos undergo spontaneous contrac-
tion indicating that their excitation-contraction coupling is
functional in these cells (Mesaeli, N., and M. Michalak, un-
published observations). This implies that Ca21 handling
by the ER, but not by the cardiac sarcoplasmic reticulum,
is affected in calreticulin knockout cardiomyocytes. ER
and sarcoplasmic reticulum membranes may form sepa-
rate functional entities in muscle cells (Tharin et al., 1996).
An intriguing finding of this work is that calreticulin-
deficient mice develop omphalocele (umbilical hernia). At
the early stages of embryogenesis the small intestine de-
velops outside the body to form a physiological umbilical
hernia. However, in 15.5-d-old embryos the intestine en-
ters the body cavity and the body wall closes (only the um-
bilical cord and its contents remain in this region) (Kauf-
man, 1992). Failure of the intestine to return to the coelom
results in an omphalocele (Byrne, 1991).
Recent studies indicate that umbilical hernia is associ-
ated with the function of a cyclin-dependent kinase inhibi-
tory protein p57KIP2, a regulator of cell proliferation (Egg-
enschwiler et al., 1997; Zhang et al., 1997). IGF-II receptor
mutation and overexpression of IGF-II also results in
omphalocele (Eggenschwiler et al., 1997). Disruption of
the MARCKS gene that encodes a substrate of protein ki-
nase C also leads to an omphalocele (Stumpo et al., 1995;
Chen et al., 1996). Protein kinase C is activated by Ca21,
suggesting that Ca21 release from the ER may play an im-
portant role in the closure of umbilical hernia. GATA-4
transcription factor is also expressed during gut develop-
ment by playing a role in the regulation of intestine epithe-
lial cell differentiation (Gao et al., 1998). It is conceivable
Figure 10. Inhibition of nuclear import of NF-
AT3 transcription factor in crt2/2 cells. Mouse
embryonic fibroblasts isolated from 14.5-d-old
crt1/2 (row A) and crt2/2 (rows B and C) em-
bryos were transiently transfected with either
NF-AT3 (rows A and B) or NF-AT3 and calre-
ticulin (row C) expression vectors. A, B, and C
show localization of calreticulin, while A9, B9,
and C9 show localization of NF-AT3 in the same
cells. Cells were stimulated with 200 nM bradyki-
nin. A9 shows that in the stimulated crt1/2 cells
NF-AT3 translocates to the nucleus. In crt2/2
cells the majority of NF-AT3 is found in the cy-
toplasm (B9). In crt2/2 cells transfected with cal-
reticulin expression vector, NF-AT3 is again able
to translocate the nucleus after stimulation (C9).
A0, B0, and C0 are phase-contrast images of the
same cells. Bar, 25 mm.The Journal of Cell Biology, Volume 144, 1999 866
that a similar Ca21/calcineurin/NF-AT/GATA-4 transcrip-
tion pathway may be activated during cardiac develop-
ment and closure of umbilical hernia. This may explain
why NF-AT3–deficient mice also show signs of abdominal
necrosis (de la Pompa et al., 1998).
In Fig. 12 we present a model in which calreticulin is
linked to NF-AT function and cardiac development. Ca21
release through the InsP3-dependent pathway is required
to activate calcineurin and to maintain NF-AT transcrip-
tion factor in the nucleus (Timmerman et al., 1996; Dol-
metsch et al., 1997). We propose that calreticulin regulates
calcineurin activity indirectly by affecting Ca21 release
from the ER and the ability of NF-AT to translocate to the
nucleus (Fig. 12). This model is supported by our demon-
stration that InsP3-dependent Ca21 release is inhibited in
calreticulin-deficient cells, concomitant with the inhibition
of the NF-AT nuclear import.
The role of the InsP3 receptor and the InsP3-dependent
pathway in cardiac development is further supported by
studies on another regulator of the InsP3 receptor and
Ca21 release, the immunophilin protein FKBP12 (FK506
binding protein) (Brillantes et al., 1994; Cameron et al.,
1995). Knockout of the FKBP12 gene is also embryonic le-
thal and the animals show cardiac defects (Shou et al.,
1998). FKBP12 could be considered as a cytosolic regula-
tor of the ER Ca21 release channel, whereas calreticulin
could be a lumenal regulator of Ca21 homeostasis. The
calreticulin/Ca21/calcineurin/NF-AT/GATA-4 regulatory
pathway is critical for the developing heart (Molkentin et al.,
1998), but it is likely to be switched off in the adult myo-
cardium and many components are absent or present at
very low levels (NF-AT, GATA-4, and calreticulin) in the
mature cardiomyocytes (de la Pompa et al., 1998; Fliegel
et al., 1989a,b; Molkentin et al., 1998, and the references
therein). In mature organisms NF-AT and calreticulin may
play a more important role in the immune response
(Burns et al., 1992; Dupuis et al., 1993; Rao et al., 1997;
Andrin et al., 1998). Our results demonstrate an essential
role for calreticulin during embryogenesis. Although cal-
reticulin is not a transcription factor, this work shows that
the protein is a regulator of Ca21 homeostasis and of tran-
scriptional pathways involved in cardiac development.
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